Buy Rioteph 1.5 mg (Riociguat) – Generic Adempas for Pulmonary Hypertension

Rioteph 1.5 mg is a generic form of riociguat (Adempas), indicated for treating adults with pulmonary arterial hypertension (PAH) or persistent/residual chronic thromboembolic pulmonary hypertension (CTEPH) after surgery or where surgery is not suitable.

How It Works

Riociguat stimulates soluble guanylate cyclase, boosting cyclic GMP levels. This promotes vasodilation in pulmonary arteries, lowering vascular resistance and improving exercise capacity and breathing in PAH or CTEPH patients.

Indications & Benefits

• Treats PAH (WHO Group 1) and non-operable or persistent CTEPH (Group 4).
• Improves walking distance, WHO functional status, and delays clinical progression.
• Used alone or combined with other PAH therapies when needed.

Dosage & Titration Process

• Usual starting dose: 1.5 mg TID (three times daily). If hypotensive risk or strong CYP/P-gp inhibitors, begin at 0.5–1.0 mg TID.
• Increase by 0.5 mg per dose every two weeks up to 2.5 mg TID, based on BP and side effects. Monitor systolic BP ≥95 mmHg before each increase.
• Smokers may require higher doses due to increased metabolism; reduce if they quit during therapy.

Side Effects & Warnings

• Common: headache, dizziness, nausea, low blood pressure, edema—dose-related and often transient.
• Serious: syncope, bleeding, anemia, fetal harm in pregnancy. Women of childbearing potential must use effective contraception and typically enroll in a REMS-like program.
• Contraindicated with nitrates or PDE‑5 inhibitors (e.g., sildenafil, tadalafil)—risk of severe hypotension.

Precautions & Drug Interactions

• Avoid strong CYP/P-gp/BCRP inhibitors—they increase riociguat levels. Start low and monitor blood pressure. 
• Do not combine with nitrates or PDE‑5 inhibitors—can dangerously lower BP. Avoid grapefruit and similar inhibitors.
• Not for patients with severe renal (<15 mL/min) or Child‑Pugh C hepatic impairment.
• Self-contained doses must not be doubled if missed—maintain schedule and re-titrate if interrupted ≥3 days. 

Global Availability & Prescription Info

Rioteph 1.5 mg is prescription-only, sourced via licensed pharmacies (e.g. Cipla). Discreet international shipping and tracking available. Specialist oversight recommended due to REMS compliance and pulmonary hypertension monitoring.

📌 Frequently Asked Questions (FAQs)

1. What does Rioteph 1.5 mg treat?

Approved for PAH and non-surgical or residual CTEPH in adults; improves exercise performance and delays disease progression. 

2. What is the starting dose?

Generally 1.5 mg three times daily. Start with 0.5–1.0 mg TID if hypotension risk or CYP/P-gp inhibitors are in use. Increment by 0.5 mg every 2 weeks up to 2.5 mg TID. 

3. What common side effects might occur?

Mild effects include dizziness, headache, indigestion, edema, and fainting. Severe hypotension or bleeding events are rare but require medical attention. 

4. Can I take other medications with it?

Do not take nitrates or PDE‑5 inhibitors (e.g., Viagra, Cialis) within 24–48 hours—very dangerous. Avoid grapefruit. Adjust doses when combined with CYP3A4 or P‑gp inhibiting drugs.

5. Is Rioteph safe during pregnancy?

No—riociguat is teratogenic. Women of childbearing age must use effective contraception and participate in a risk management program.